Barclays’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $621K | Buy |
393,309
+44,799
| +13% | +$75.5K | ﹤0.01% | 3057 |
|
|
2025
Q4 | $582K | Buy |
348,510
+348,509
| +34,850,900% | +$603K | ﹤0.01% | 3760 |
|
|
2025
Q3 | $2 | Sell |
1
-26,438
| -100% | -$31.3K | ﹤0.01% | 5435 |
|
|
2025
Q2 | $24K | Sell |
26,439
-168,606
| -86% | -$100K | ﹤0.01% | 4826 |
|
|
2025
Q1 | $88.1K | Sell |
195,045
-39,024
| -17% | -$22.9K | ﹤0.01% | 4452 |
|
|
2024
Q4 | $118K | Buy |
234,069
+22,769
| +11% | +$16.7K | ﹤0.01% | 4556 |
|
|
2024
Q3 | $191K | Buy |
211,300
+159,924
| +311% | +$148K | ﹤0.01% | 4325 |
|
|
2024
Q2 | $51.2K | Sell |
51,376
-42,551
| -45% | -$47K | ﹤0.01% | 4205 |
|
|
2024
Q1 | $139K | Sell |
93,927
-89,365
| -49% | -$101K | ﹤0.01% | 4300 |
|
|
2023
Q4 | $200K | Buy |
183,292
+159,296
| +664% | +$174K | ﹤0.01% | 4419 |
|
|
2023
Q3 | $28.3K | Sell |
23,996
-1,909
| -7% | -$2.6K | ﹤0.01% | 4078 |
|
|
2023
Q2 | $36.5K | Buy |
25,905
+12,075
| +87% | +$16.7K | ﹤0.01% | 3964 |
|
|
2023
Q1 | $20.7K | Sell |
13,830
-14,279
| -51% | -$19.9K | ﹤0.01% | 4652 |
|
|
2022
Q4 | $32.9K | Buy |
28,109
+20,472
| +268% | +$25.8K | ﹤0.01% | 4692 |
|
|
2022
Q3 | $9K | Buy |
+7,637
| New | +$11.2K | ﹤0.01% | 4358 |
|
|
2022
Q2 | – | Sell |
-20,360
| Closed | -$31K | – | 5159 |
|
|
2022
Q1 | $31K | Buy |
+20,360
| New | +$31.6K | ﹤0.01% | 4298 |
|
|
2019
Q3 | – | Sell |
-71,999
| Closed | -$79K | – | 6945 |
|
|
2019
Q2 | $79K | Buy |
71,999
+39,757
| +123% | +$45.8K | ﹤0.01% | 5853 |
|
|
2019
Q1 | $42K | Buy |
32,242
+30,862
| +2,236% | +$38.4K | ﹤0.01% | 6001 |
|
|
2018
Q4 | $1K | Sell |
1,380
-44,111
| -97% | -$67.6K | ﹤0.01% | 6809 |
|
|
2018
Q3 | $93K | Buy |
45,491
+31,940
| +236% | +$67.1K | ﹤0.01% | 5605 |
|
|
2018
Q2 | $25K | Sell |
13,551
-70,956
| -84% | -$143K | ﹤0.01% | 6056 |
|
|
2018
Q1 | $199K | Buy |
84,507
+4,914
| +6% | +$11.5K | ﹤0.01% | 4836 |
|
|
2017
Q4 | $150K | Buy |
79,593
+76,447
| +2,430% | +$167K | ﹤0.01% | 4925 |
|
|
2017
Q3 | $8K | Buy |
3,146
+1,942
| +161% | +$4.82K | ﹤0.01% | 6231 |
|
|
2017
Q2 | $3K | Sell |
1,204
-1,479
| -55% | -$4.13K | ﹤0.01% | 6348 |
|
|
2017
Q1 | $7K | Buy |
2,683
+464
| +21% | +$1.32K | ﹤0.01% | 6184 |
|
|
2016
Q4 | $6K | Sell |
2,219
-749
| -25% | -$2.3K | ﹤0.01% | 6078 |
|
|
2016
Q3 | $11K | Buy |
2,968
+1,827
| +160% | +$5.05K | ﹤0.01% | 5753 |
|
|
2016
Q2 | $2K | Hold |
1,141
| – | – | ﹤0.01% | 5959 |
|
|
2016
Q1 | $2K | Sell |
1,141
-5,210
| -82% | -$11.6K | ﹤0.01% | 5867 |
|
|
2015
Q4 | $21K | Buy |
6,351
+3,529
| +125% | +$10.5K | ﹤0.01% | 5173 |
|
|
2015
Q3 | $7K | Sell |
2,822
-27,279
| -91% | -$70.6K | ﹤0.01% | 5926 |
|
|
2015
Q2 | $73K | Sell |
30,101
-31,096
| -51% | -$121K | ﹤0.01% | 4900 |
|
|
2015
Q1 | $197K | Buy |
61,197
+54,805
| +857% | +$190K | ﹤0.01% | 4355 |
|
|
2014
Q4 | $16K | Sell |
6,392
-397
| -6% | -$1.07K | ﹤0.01% | 6441 |
|
|
2014
Q3 | $17K | Sell |
6,789
-10,340
| -60% | -$24.9K | ﹤0.01% | 6583 |
|
|
2014
Q2 | $42K | Buy |
17,129
+4,833
| +39% | +$10.9K | ﹤0.01% | 6067 |
|
|
2014
Q1 | $29K | Buy |
12,296
+167
| +1% | +$492 | ﹤0.01% | 6389 |
|
|
2013
Q4 | $29K | Sell |
12,129
-1,313
| -10% | -$3.97K | ﹤0.01% | 6510 |
|
|
2013
Q3 | $32K | Buy |
13,442
+2,368
| +21% | +$7.49K | ﹤0.01% | 6302 |
|
|
2013
Q2 | $36K | Buy |
+11,074
| New | +$35.5K | ﹤0.01% | 6526 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
